Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

New

Protein Expression Market By Product (Reagents, Expression vectors, Competent cells, Instruments and Services), Application (Therapeutic, Industrial, Research): Global Opportunity Analysis and Industry Forecast, 2019–2026

A06098
Pages: 146
Mar 2020 | 945 Views
 
Author(s) : Sanjivan Gill & Onkar Sumant
Tables: 81
Charts: 38
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Protein Expression Market

Request Now !

The global protein expression market was valued at $2,121 million in 2018 and is projected to reach $4,611 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Protein expression refers to a biotechnological process of generating specific protein, typically attained by manipulation of gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled expression and isolation of recombinant proteins in large scale. One of the major achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to completely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellularly operating enzymes though therapeutic protein. The first expression platform established was prokaryotic system through Escherichia coli. This was followed by development of other expression systems including yeast, algae, insect, and mammalian. 

Protein Expression Market

Get more information on this report : Request Sample Pages

Protein expression finds major application in research, industrial and therapeutics and others. The therapeutic proteins such as peptide hormones, vaccines, monoclonal antibodies, therapeutic enzymes, antibodies, blood factors and cytokines are widely used to treat various chronic diseases such as cancer, diabetes, and multiple sclerosis. These proteins have elevated quality, accuracy and efficiency in biologics production.  

The factors that boost the growth of the protein expression market include rise in geriatric population, age-related diseases and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market.

Improvements in innovations such as mass spectrometry, advancements in molecular genetics and advancement in manufacturing techniques are all key drivers on the protein therapy market. Furthermore, rapid developments in medical technology, better disease detection, and healthcare growth in emerging markets should have positive market impact.

Global Protein Expression Market Segmentation  

The global protein expression market is segmented based on product, application, and region. Based on product, the market is bifurcated into reagents, expression vectors, competent cells, instruments, and services. By application, it is divided into therapeutic, industrial, and research. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Some of the key players operating in the protein expression market include Agilent Technologies, Inc, Becton, Dickinson & Company, Bio Rad Laboratories, GenScript Biotech Corporation, LifeSensors Inc., Merck KGaA, Promega Corporation, QIAGEN N.V., Takara Holdings Inc. and Thermo Fisher Scientific Inc.

Protein Expression Market
By Product

Your browser does not support the canvas element.

Competent cells is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Segment review

Based on product, protein expression market is bifurcated into reagents, expression vectors, competent cells, instruments and services. The reagents segment is expected to grow at a CAGR of 8.9% during the forecast period. The process of protein expression includes the use of reagents such as acids & bases, acrylamides, buffers, cell lysis of carbohydrates, detergents, general reagents, protease inhibitors and solvents. For research, industrial and pharmaceutical processing, these reagents have applications. It is therefore expected that repetitive buying of reagents for different applications will boost market growth.
The therapeutics segment was the highest contributor to the market in 2018, and the industrial and research segments are expected to witness significant CAGRs of 10.3% and 12.3%, respectively, during the forecast period.

Protein Expression Market
By Application

Your browser does not support the canvas element.

Therapeutic market holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Snapshot of region   

Country wise, North America presents significant opportunities for the key players operating in the protein expression market, and Asia-Pacific is expected to witness significant CAGR of 11.2%, during the forecast period. This region offers lucrative opportunities for the protein market and is anticipated to register the highest growth rate during the forecast period. Moreover, increase in healthcare expenditure and surge in applications of protein expression is another major factor that boosts the growth of the market. In addition, presence of key players in these regions also fuels the growth of the protein expression in Asia-Pacific. 

The key players profiled in this report include Agilent Technologies, Inc, Becton, Dickinson & Company, Bio Rad Laboratories, GenScript Biotech Corporation, LifeSensors Inc., Merck KGaA, Promega Corporation, QIAGEN N.V., Takara Holdings Inc. and Thermo Fisher Scientific Inc.

Protein Expression Market
By Geography

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 11.2% during 2019-2026.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders:

  • The study provides an in-depth analysis of the protein expression market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers protein expression market analysis from 2019 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities. 
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global protein expression market growth.

Key Market Segments:

By Product 

  • Reagents
  • Expression vectors
  • Competent cells
  • Instruments
  • Services

By Application 

  • Therapeutic
  • Industrial
  • Research

By Region

  • North America
    • U.S. 
    • Canada
    • Mexico
  • Europe 
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe 
  • Asia-Pacific 
    • Japan
    • China
    • India 
    • Rest of Asia-Pacific
  • LAMEA 
    • Latin America
    • Middle-East 
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET DYNAMICS

3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Top player positioning
3.4. Market dynamics

3.5. Drivers

3.5.1. Surge in prevalence of chronic disease
3.5.2. Surge in healthcare expenditure worldwide:

3.6. Restraint

3.6.1. Stringent regulatory approval

3.7. Opportunities

3.7.1. Rise in pharmaceutical market in emerging regions

CHAPTER 4: GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT

4.1 Overview

4.1.1. Market size and forecast

4.2. Reagents

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region

4.3. Expression Vectors

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Competent Cells

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region

4.5. Instruments

4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region

4.6. Services

4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast, by region

CHAPTER 5: PROTEIN EXPRESSION MARKET, BY APPLICATION

5.1.1. OVERVIEW
5.1.2. Market size and forecast

5.2. Therapeutic

5.2.1. Market size and forecast, by region

5.3. Industrial

5.3.1. Market size and forecast, by region

5.4. Research

5.4.1. Market size and forecast, by region

CHAPTER 6: PROTEIN EXPRESSION MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. North America Protein Expression Market, by country

6.2.2.1. U.S.

6.2.2.1.1 U.S. market size and forecast, by product
6.2.2.1.2 U.S. market size and forecast, by application

6.2.2.2. Canada

6.2.2.2.1 Canada market size and forecast, by application

6.2.2.3. Mexico

6.2.2.3.1 Mexico market size and forecast, by product
6.2.2.3.2 Mexico market size and forecast, application

6.3. Europe

6.3.1. Key market trends and opportunities
6.3.2. Europe protein expression market, by country

6.3.2.1. Germany

6.3.2.1.1. Germany market size and forecast, by product
6.3.2.1.2. Germany market size and forecast, by application

6.3.2.2. France

6.3.2.2.1 France market size and forecast, by product
6.3.2.2.2 France market size and forecast, by application

6.3.2.3. UK

6.3.2.3.1 UK market size and forecast, by product
6.3.2.3.2 UK market size and forecast, by application

6.3.2.4. Italy

6.3.2.4.1 Italy market size and forecast, by product
6.3.2.4.2 Italy market size and forecast, by application

6.3.2.5. Spain

6.3.2.5.1 Spain market size and forecast, by product
6.3.2.5.2 Spain market size and forecast, by application

6.3.2.6. Rest of Europe

6.3.2.6.1 Rest of Europe market size and forecast, by product
6.3.2.6.2 Rest of Europe market size and forecast, by application
6.3.2.6.3 Europe market size and forecast, by product
6.3.2.6.4 Europe market size and forecast, by application

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific Protein Expression market, by country

6.4.2.1. Japan

6.4.2.1.1 Japan market size and forecast, by product
6.4.2.1.2 Japan market size and forecast, by application

6.4.2.2. China

6.4.2.2.1 China market size and forecast, by product
6.4.2.2..2 China market size and forecast, by application

6.4.2.3. India

6.4.2.3.1 India market size and forecast, by application

6.4.2.4. Rest of Asia-Pacific

6.4.2.4.1 Rest of Asia-Pacific market size and forecast, by product
6.4.2.4.2 Rest of Asia-Pacific market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by PRODUCT
6.4.4. Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA protein expression market, by country

6.5.2.1. Latin America
6.5.2.2. Middle East
6.5.2.3. Rest of LAMEA

6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by application

CHAPTER 7: COMPANY PROFILES

7.1. AGILENT TECHNOLOGIES, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance

7.2. BECTON, DICKINSON AND COMPANY

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance

7.3. BIO-RAD LABORATORIES, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance

7.4. GenScript Biotech Corporation

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. LifeSensors Inc.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. Merck KGaA

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. Promega Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio

7.8. QIAGEN N.V.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance

7.9. Takara Holdings Inc.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance

7.10. THERMO FISHER SCIENTIFIC, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. PROTIEN EXPRESSION MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. PROTEIN EXPRESSION MARKET FOR REAGENTS, BY REGION 2018–2026 ($MILLION)
TABLE 03. PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION 2018–2026 ($MILLION)
TABLE 04. PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION 2018–2026 ($MILLION)
TABLE 05. PROTEIN EXPRESSION MARKET FOR INSTRUMNETS, BY REGION 2018–2026 ($MILLION)
TABLE 06. PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 07. PROTIEN EXPRESSION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08. PROTEIN EXPRESSION MARKET FOR THERAPEUTIC, BY REGION 2018–2026 ($MILLION)
TABLE 09. PROTEIN EXPRESSION MARKET FOR INDUSTRIAL, BY REGION 2018–2026 ($MILLION)
TABLE 10. PROTEIN EXPRESSION MARKET FOR RESEARCH, BY REGION 2018–2026 ($MILLION)
TABLE 11. PROTEIN EXPRESSION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 13. U.S. PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 14. U.S. PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 15. CANADA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 16. CANADA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 17. MEXICO PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 18. MEXICO PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 19. EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 21. GERMANY PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 22. FRANCE PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 23. FRANCE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 24. UK PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 25. UK PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 26. ITALY PRODUCT EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 27. ITALY PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 28. SPAIN PROTEIN EXPRESSION REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 29. SPAIN PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 30. REST OF EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 31. REST OF EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 32. EUROPE PROTEIN EXPRESION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 33. EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 34. ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. JAPAN PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 36. JAPAN PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 37. CHINA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 38. CHINA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 39. INDIA PROTIEN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 40. INDIA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 41. REST OF ASIA-PACIFIC PROTIEN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 42. REST OF ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 43. ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 44. ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 45. LAMEA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. LATIN AMERICA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 47. LATIN AMERICA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 48. MIDDLE EAST PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 49. MIDDLE EAST PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 50. REST OF LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 51. REST OF LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 52. LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 53. LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 54. AGILENT: COMPANY SNAPSHOT
TABLE 55. AGILENT: OPERATING SEGMENTS
TABLE 56. AGILENT: PRODUCT PORTFOLIO
TABLE 57. BD: SNAPSHOT
TABLE 58. BD: OPERATING SEGMENTS
TABLE 59. BD: PRODUCT PORTFOLIO
TABLE 60. BIO-RAD: COMPANY SNAPSHOT
TABLE 61. BIO-RAD: OPERATING SEGMENTS
TABLE 62. BIO-RAD: PRODUCT PORTFOLIO
TABLE 63. GENSCRIPT: COMPANY SNAPSHOT
TABLE 64. GENSCRIPT: OPERATING SEGMENTS
TABLE 65. GENSCRIPT: PRODUCT PORTFOLIO
TABLE 66. LIFESENSORS: COMPANY SNAPSHOT
TABLE 67. LIFESENSORS: PRODUCT PORTFOLIO
TABLE 68. MERCK GROUP: COMPANY SNAPSHOT
TABLE 69. MERCK GROUP: OPERATING SEGMENTS
TABLE 70. MERCK GROUP: PRODUCT PORTFOLIO
TABLE 71. PROMEGA: COMPANY SNAPSHOT
TABLE 72. PROMEGA: PRODUCT PORTFOLIO
TABLE 73. QIAGEN: COMPANY SNAPSHOT
TABLE 74. QIAGEN: OPERATING SEGMENTS
TABLE 75. QIAGEN: PRODUCT PORTFOLIO
TABLE 76. TAKARA: COMPANY SNAPSHOT
TABLE 77. TAKARA: OPERATING SEGMENTS
TABLE 78. TAKARA: PRODUCT PORTFOLIO
TABLE 79. THERMO FISHER: COMPANY SNAPSHOT
TABLE 80. THERMO FISHER: OPERATING SEGMENTS
TABLE 81. THERMO FISHER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL PROTEIN EXPRESSION MARKET SEGMENTATION
FIGURE 02. LOW MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. MODERATE BARGAINING POWER OF BUYER
FIGURE 04. HIGH THREAT OF SUBSTITUTES
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW COMPETITIVE RIVALARY
FIGURE 07. TOP PLAYER POSITIONING, 2018
FIGURE 08. DRIVERS AND RESTRAINTS
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR INDUSTRIAL, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR RESEARCH, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. AGILENT: NET SALES, 2016–2018 ($MILLION)
FIGURE 17. AGILENT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 18. AGILENT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 19. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. BD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 22. BIO-RAD: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BIO-RAD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BIO-RAD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. GENSCRIPT: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 28. MERCK GROUP: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. MERCK GROUP: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. MERCK GROUP: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. QIAGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. QIAGEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. QIAGEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. TAKARA: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. TAKARA: NET SALES BY SEGMENTS, 2018 (%)
FIGURE 36. TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. THERMO FISCHER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38. THERMO FISCHER: REVENUE SHARE BY REGION, 2018 (%)

 
 

Protein expression is defined as a biotechnological procedure, which includes generation of precise proteins. These proteins are formed through manipulation of gene expression in organisms of interest. The procedure leads to expression of large amounts of recombinant gene in organisms. Furthermore, this has led to many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. This, in turn, has led to advancements in genetic engineering and recombinant technologies. Significant advancements in the field of biotechnology have enabled expression and isolation of recombinant proteins on large scale. Some of products which are used to perform protein expression present in the market include reagents, expression vectors, competent cells, instruments, and others. These products are used in designing therapeutics and conducting research related to medicines.

According to CXOs of leading companies in the market, protein expressions are expected to witness high adoption in the future, owing to high requirement for protein research in novel drug designing for several chronic diseases such as cancer. Moreover, increase in spending on protein research also fuels the growth of the protein expression market. Moreover, rise in adoption of protein expressions is another factor that fuels the growth of the market. Asia-Pacific and LAMEA are expected to offer lucrative growth opportunities to the key players. This is majorly attributed to factors such as improvement in healthcare facilities, rise in disposable income, and rapid improvement in economic conditions. However, stringent regulations required for the production of protein drugs hinders the growth of the protein expression market. Protein Expression manufacturers and distributors have focused on expanding their presence in emerging economies to strengthen their foothold in the market.

 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The market value of global protein expression market was $2,121 million in 2018.

A. The forecast period is from 2019 to 2026.

A. The market value of global protein expression market in 2019 is $2,337 million.

A. Rise in geriatric population, increase in age-related and chronic diseases and increased spending on R&D expenditure fuel the growth of the market

A. The base year calculated in the report is 2018.

A. The services segments are growing at a rapid growth rate owing the increasing R&D expenditure from pharmaceutical and biotechnology companies and increasing application in therapeutics and research applications.

A. Rapid developments in medical technology, better disease detection, and healthcare growth in emerging markets should have positive market impact.

A. The North America market held a major share in the global protein expression market in 2018 and Asia-Pacific is fastest growing region in the forecasting period. This is attributed to increase in healthcare expenditure and surge in applications of protein expression is another major factor that boosts the growth of the market. In addition, presence of key players in these regions also fuels the growth of the protein expression in Asia-Pacific

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Protein Expression Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/m
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts